Mylan quarterly profit, 2019 forecast miss Wall Street estimates — stock tanks

Generic drugmaker Mylan on Tuesday reported lower-than-expected fourth-quarter profit and forecast 2019 earnings well below Wall Street estimates, as it grapples with significant problems at its Morgantown, West Virginia, plant. Health and Science U.S.HEALTHCARE UPDATE: Click today to request your…

Sen. James Inhofe Bought Defense Stock Days After Pushing For Record Pentagon Spending—Then Dumped It When Asked About It

Chip Somodevilla/Getty Just days after signaling his support for unprecedented levels of U.S. defense spending, Sen. James Inhofe (R-OK), the chairman of the Senate Armed Services Committee, reported purchasing tens of thousands of dollars of stock in one of the…